Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.

Krämer A, Bochtler T, Pauli C, Shiu KK, Cook N, Janoski de Menezes J, Pazo-Cid RA, Losa F, Robbrecht DGJ, Tomášek J, Arslan C, Özgüroğlu M, Arni P, Bigot F, Kim SY, Naito Y, Italiano A, Chalabi N, Durán-Pacheco G, Ma N, Scarato J, Ross JS, Moch H, Mileshkin L

Open source

DOI: 10.1200/jco-25-02974
Published: 2026 Sep 3
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-02974,
  title = {Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.},
  author = {Krämer A and Bochtler T and Pauli C and Shiu KK and Cook N and Janoski de Menezes J and Pazo-Cid RA and Losa F and Robbrecht DGJ and Tomášek J and Arslan C and Özgüroğlu M and Arni P and Bigot F and Kim SY and Naito Y and Italiano A and Chalabi N and Durán-Pacheco G and Ma N and Scarato J and Ross JS and Moch H and Mileshkin L},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-02974},
  url = {https://doi.org/10.1200/jco-25-02974}
}

RIS

TY  - JOUR
TI  - Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
AU  - Krämer A
AU  - Bochtler T
AU  - Pauli C
AU  - Shiu KK
AU  - Cook N
AU  - Janoski de Menezes J
AU  - Pazo-Cid RA
AU  - Losa F
AU  - Robbrecht DGJ
AU  - Tomášek J
AU  - Arslan C
AU  - Özgüroğlu M
AU  - Arni P
AU  - Bigot F
AU  - Kim SY
AU  - Naito Y
AU  - Italiano A
AU  - Chalabi N
AU  - Durán-Pacheco G
AU  - Ma N
AU  - Scarato J
AU  - Ross JS
AU  - Moch H
AU  - Mileshkin L
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-02974
UR  - https://doi.org/10.1200/jco-25-02974
ER  -

APA

A, K., T, B., C, P., KK, S., N, C., J, J. D. M., RA, P., F, L., DGJ, R., J, T., C, A., M, Ö., P, A., F, B., SY, K., Y, N., A, I., N, C., G, D., N, M., J, S., JS, R., H, M., & L, M. (2026). Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-02974

Source records

pubmed · retrieved 2026-09-26T00:35:56.389Z
europe-pmc · retrieved 2026-09-26T00:35:56.398Z